Vimarsana
Biggest News Aggregation in the World

Ctrlm Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ctrlm Health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ctrlm Health Today - Breaking & Trending Today

FDA approval of Zavzpret provides another critical tool to combat migraine - Vimarsana News

FDA approval of Zavzpret provides another critical tool to combat migraine

Published: April 7, 2023

The FDA approval of Zavzpret, which Pfizer announced in March 2023, is good news for people living with migraine, as it becomes an important option to help combat this disease.

Source: healio.com
Related Topics:
United StatesAllergan AbbvieHeather BieleMichigan State University College Of Human MedicineAmerican Headache SocietyDisparities In Headache Advisory CouncilCtrlm HealthAmerican Academy Of NeurologyMichigan State UniversityThomas Jefferson UniversityClinical Neurological Society Of AmericaHeadache Advisory CouncilAmerican AcademyMichigan State University CollegeHuman MedicineThomas JeffersonFace PainClinical Neurological SocietyMichigan State
More Positive Phase 3 Results 'Raise the Bar' for Migraine Drug - Vimarsana News

More Positive Phase 3 Results 'Raise the Bar' for Migraine Drug

Published: June 23, 2022

Secondary analyses of the phase 3 ADVANCE trial showed atogepant, a CGRP receptor antagonist, is superior to placebo across several migraine responder outcomes.

Source: medscape.com
Related Topics:
New YorkUnited StatesRichardb LiptonElizabeth LoderEli LillyAllergan AbbvieDepartment Of NeurologyAlbert Einstein College Of MedicineHarvard Medical SchoolMontefiore Headache CenterBiodelivery Sciences InternationalAcademic AffairsCtrlm HealthAlbert Einstein CollegeMedscape MedicalMedscape Medical NewsThenew England JournalPatient Global ImpressionMigraine HeadacheEadache Migraine